Founded
2022
Stage
Seed
Team size
1-10 employees
Sector
Health & Life Sciences
About
Biopharmaceutical company developing SRC-3 knock-out regulatory T-cell (Treg) immunotherapies to treat aggressive solid-tumor cancers, based on Baylor College of Medicine research.